Cargando…
Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome
BACKGROUND: Despite notable advances in the support and treatment of patients admitted to the intensive care unit (ICU), the management of those who develop a systemic inflammatory response syndrome (SIRS) still constitutes an unmet medical need. MAIN BODY: Both the initial injury (trauma, pancreati...
Autores principales: | Martí‐Chillón, Gerardo‐Javier, Muntión, Sandra, Preciado, Silvia, Osugui, Lika, Navarro‐Bailón, Almudena, González‐Robledo, Javier, Sagredo, Víctor, Blanco, Juan F., Sánchez‐Guijo, Fermín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806020/ https://www.ncbi.nlm.nih.gov/pubmed/36588089 http://dx.doi.org/10.1002/ctm2.1163 |
Ejemplares similares
-
Eltrombopag increases the hematopoietic supporting ability of
mesenchymal stem/stromal cells
por: Muntión, Sandra, et al.
Publicado: (2022) -
Co-administration of human MSC overexpressing HIF-1α increases human CD34(+) cell engraftment in vivo
por: Preciado, Silvia, et al.
Publicado: (2021) -
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
por: López, Raúl, et al.
Publicado: (2021) -
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34(+) Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
por: Preciado, Silvia, et al.
Publicado: (2019) -
Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?
por: Martin-Rufino, Jorge Diego, et al.
Publicado: (2019)